Crinetics Pharmaceuticals, Inc. (CRNX) Operating income 2016–2025
Crinetics Pharmaceuticals, Inc. (CRNX) annual operating income history from SEC filings — each fiscal year as reported.
-$516.8MFY2025 · since FY2016: -$6.0M → -$516.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$516.8M | -52.5% |
| FY2024 | -$338.9M | -52.2% |
| FY2023 | -$222.6M | -32.6% |
| FY2022 | -$167.9M | -55.9% |
| FY2021 | -$107.7M | -43.7% |
| FY2020 | -$75.0M | -39.2% |
| FY2019 | -$53.8M | -87.5% |
| FY2018 | -$28.7M | -214.6% |
| FY2017 | -$9.1M | -51.0% |
| FY2016 | -$6.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice